Aprovel Irbesartan 150 mg

Aprovel is a brand-name pharmaceutical product used primarily to treat hypertension (high blood pressure) and kidney disease in patients with type 2 diabetes. Its active pharmaceutical ingredient (API), Irbesartan, belongs to the class of medications known as angiotensin II receptor blockers (ARBs).

The brand was originally developed through a strategic partnership between the French pharmaceutical giant Sanofi (then Sanofi-Synthélabo) and the American firm Bristol-Myers Squibb. While manufacturing takes place at various global sites to meet international demand, significant production facilities for this drug are located in France. Today, Sanofi serves as the primary ultimate owner and distributor for Aprovel in many global markets, maintaining its status as a leader in cardiovascular health therapeutics.